Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Free Cash Flow (2021 - 2025)

PAVmed (PAVM) has 5 years of Free Cash Flow data on record, last reported at -$899000.0 in Q3 2025.

  • For Q3 2025, Free Cash Flow changed N/A year-over-year to -$899000.0; the TTM value through Sep 2025 reached -$3.6 million, changed N/A, while the annual FY2024 figure was -$33.7 million, 35.62% up from the prior year.
  • Free Cash Flow reached -$899000.0 in Q3 2025 per PAVM's latest filing, up from -$1.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $44000.0 in Q4 2024 and bottomed at -$22.9 million in Q2 2022.
  • Average Free Cash Flow over 5 years is -$10.9 million, with a median of -$11.9 million recorded in 2023.
  • Peak YoY movement for Free Cash Flow: plummeted 239.46% in 2022, then soared 100.36% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$18.1 million in 2021, then rose by 5.17% to -$17.1 million in 2022, then rose by 29.58% to -$12.1 million in 2023, then skyrocketed by 100.36% to $44000.0 in 2024, then tumbled by 2143.18% to -$899000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Free Cash Flow were -$899000.0 in Q3 2025, -$1.2 million in Q2 2025, and -$1.6 million in Q1 2025.